Imatinib (Gleevec) as a Paradigm of Targeted Cancer Therapies: Part 3: Extending the Imatinib Paradigm (22:09)

submitted by: scivee-team

The lessons learned from the clinical trials of imatinib will be reviewed in this section. This will include examples of where imatinib has or has not worked, analysis of target expression versus activation and a discussion of how the success of imatinib can be translated to other malignancies. The section concludes with what this means for research to control or cure cancer in the coming decades.